The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Stereotactic Radiosurgery for Brain Metastases: SRS Techniques and Outcomes

Precision focal radiation delivery for limited brain metastatic disease

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Stereotactic Radiosurgery for Brain Metastases: SRS Techniques and Outcomes?

Brain metastases occur in 20-40% of cancer patients with lung, breast and melanoma being most common primary sources.

SRS delivers ablative dose typically 15-24 Gy in single fraction depending on lesion size and location.

Modern systems include gamma knife with cobalt sources, linac-based platforms and proton therapy with each having advantages.

Image guidance with MRI fusion enables precise targeting and treatment planning optimization.

Patient selection traditionally limited to 1-4 lesions but expanding to higher numbers with modern evidence.

Symptoms

Brain metastasis presentation includes headache, focal neurologic deficits, seizures and cognitive changes depending on location.
Asymptomatic patients identified through staging imaging in cancer patients with significant metastatic risk.
Mass effect, edema and hemorrhage may produce acute neurologic deterioration requiring urgent management.
Performance status assessment guides treatment intensity decisions and patient selection.
Primary tumor histology and systemic disease status critically influence prognosis and treatment approach.

Risk Factors

Larger lesion size (>3 cm) increases toxicity risk and may favor fractionated delivery or surgical resection.
Eloquent brain location including motor cortex, brainstem and visual pathway requires careful planning.
Multiple lesions with high total volume challenge SRS feasibility and may favor whole brain radiation.
Prior whole brain radiation increases risk of radiation necrosis with subsequent SRS.
Active extracranial disease without effective systemic options affects overall benefit assessment.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New brain metastasis diagnosis warrants urgent multidisciplinary evaluation for optimal treatment selection.
  • Symptomatic brain metastases require prompt corticosteroid therapy and definitive treatment planning.
  • Post-SRS follow-up imaging at 2-3 month intervals monitors response and identifies progression or radiation necrosis.
  • New neurologic symptoms or imaging changes warrant evaluation distinguishing tumor progression from radiation effects.
  • Multidisciplinary tumor board review optimizes treatment sequencing with systemic therapy and surgical considerations.

Treatment Methods

01
Single-fraction SRS dose 15-24 Gy depending on lesion size with smaller lesions tolerating higher doses safely.
02
Hypofractionated stereotactic radiotherapy with 25-30 Gy in 3-5 fractions for larger lesions or eloquent locations.
03
Surgical resection for large symptomatic lesions followed by cavity SRS reducing local recurrence.
04
Integration with systemic therapy including immune checkpoint inhibitors and targeted agents enhancing brain control.
05
Post-treatment surveillance with serial MRI, management of radiation necrosis with bevacizumab or laser interstitial thermal therapy and supportive care including corticosteroids and antiseizure prophylaxis when indicated optimize outcomes for this challenging clinical scenario.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.